Post by
Deadornot on Apr 05, 2021 5:51pm
Never seen such a loss
due to EMOTIONS. If you look at the facts, we should be going up.
We're buying a company that brings in roughly $12 million per year (according to a link Jony linked the other day). Q1 we started testing travellers for COVID-19 for flights going to China, Barbados, and other (I think Q1 alone will be north of $4 million). Q4 was good. With this company we are buying, we are USING ARISTOTLE. $1,500 per test x 3000 people is $4.5 million alone just with this AVRT program. This does not include the multiple tests that the Chief Medical Officer of Care Oncology said they would do. So double that $4.5 million.
I understand the frustration.... I AM FRUSTRATED that we didn't shoot up to $5 along with a halt. But guys, think of where we'll be in 6 months.
Comment by
Skrit37 on Apr 05, 2021 5:56pm
Your assuming all 3000 patients are female then? Do you know this for a fact?
Comment by
Deadornot on Apr 05, 2021 5:59pm
Aristotle is available for both genders?
Comment by
Skrit37 on Apr 05, 2021 6:04pm
Female panel was going to be introduced 1st....I don't believe this has changed
Comment by
Deadornot on Apr 05, 2021 6:06pm
Maybe that's why Tripp said 5,000 people in the CC and 3,000 in the NR. 3000 female and 2000 male?
Comment by
Deadornot on Apr 05, 2021 6:10pm
The NR says "The partnership also gives us the necessary infrastructure to correctly cater to employers, where we go next”. Further updates on the AVRT program and the acquisition will come in the weeks ahead." I believe they're going to start off with AVRT and Care Oncology and work their way. Also, it says that it is 3000 patients PLUS family members
Comment by
Deadornot on Apr 05, 2021 5:58pm
"The partnership also gives us the necessary infrastructure to correctly cater to employers, where we go next”.